February 17, 2015

Teva Pharmaceuticals on Tuesday announced the launch of generic versions of Lovenox (enoxaparin sodium injection) as well as generic Zyvox (linezolid) injection. 

 

February 17, 2015

The flu is making its way to the Southeastern United States, according to the latest Walgreens Flu Index.

February 12, 2015

Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Thursday introduced companion legislation to House bill H.R. 471.

 

February 12, 2015

Sandoz on Thursday launched telmisartan tablets, the generic version of Micardis from Boehringer Ingelheim. The drug is used to treat hypertension, the company said.

 

February 10, 2015

From Jan. 1 to Feb. 6, 2015, 121 people from 17 states and Washington D.C. were reported to have measles.

February 10, 2015

The Generic Pharmaceutical Association on Monday announced the election of its 2015 executive committee and board of directors.

February 10, 2015

PricewaterhouseCoopers released a new spotlight on the dangers of antimicrobial resistance.

 

February 9, 2015

Under new bipartisan legislation, seniors would have more convenient access to discounted or "preferred" co-pays for prescription drugs at their pharmacy of choice.

February 9, 2015

Mylan Inc. and its subsidiary Mylan Pharmaceuticals are being sued by Bayer Healthcare, Bayer Healthcare Pharmaceuticals and Onyx Pharamceuticals in relation to the filing of an abbreviated new drug application for sorafenib tablets, the generic version of Nexavar. 

 

February 6, 2015

The pharma industry praised outgoing Food and Drug Administration commissioner Margaret Hamburg and welcomed Stephen Ostroff, who will assume the role of acting commissioner.

February 5, 2015

HDMA recognized four members of Congress with the Association’s Rx Safety and Healthcare Leadership Award.

February 5, 2015

Food and Drug Commissioner Margaret Hamburg will resign from her post in March.

 

February 5, 2015

Pfizer has entered into a definitive merger agreement to acquire Hospira.

 

February 5, 2015

Generic drug prices are going up. Spurred by market opportunities, short-term market exclusivity for some newly launched single-source generics and rising costs for manufacturing, quality control and raw materials, me-too drug manufacturers have escalated a series of price hikes, some of them significant.

February 3, 2015

Teva Pharmaceuticals on Tuesday announced the introduction of dexmethylphenidate hydrochloride extended-release capsules, CII, in 10-mg dosage strength.

February 3, 2015

Camber Pharmaceuticals on Tuesday announced the launch of rizatriptan benzoate tablets in 5- and 10-mg dosage strengths. 

 

February 2, 2015

Mylan announced that it will acquire certain businesses from specialty women's healthcare company Famy Care Limited for $750 million, with additional contingent payments of up to $50 million. 

January 29, 2015

Cardinal Health increased full-year share earnings projections to a range of $4.28 to $4.38, in part driven by a faster-than-expected start for its generics sourcing venture with CVS Health.

January 28, 2015

The House Energy and Commerce Committee on Tuesday released a discussion document in the 21st Century Cures initiative.

January 28, 2015

"During one of the sessions at the 2008 NACDS Regional Chain Conference, we projected onto the video screen some images of advertisements that NACDS was beginning to use in the Washington, D.C. area. Looking back, one of the things that I remember most was the boldness and strategic focus of the tagline: 'Pharmacies. The face of neighborhood healthcare.' With the 2015 edition of this meeting just days away, it is striking how far we have come!" writes NACDS president and CEO Steve Anderson in his latest blog post. 

January 27, 2015

Actavis on Monday agreed to acquire Auden Mckenzie Holdings for approximately $465.8 million in cash, plus a two-year royalty on a percentage of gross profits of one of Auden Mckenzie's products.

January 27, 2015

Rep. Jason Chaffetz, R-Utah, last week introduced a bill that would extend to new combination drugs containing molecules already approved by the Food and Drug Administration the same five-year market exclusivity as a drug product containing an entirely new set of active ingredients.

January 27, 2015

The Food and Drug Administration on Monday announced approval for the first generic version of Nexium (esomeprazole magnesium delayed-release capsules), which are used to treat gastroesophageal reflux disease in adults and children ages 1 year and older.

January 27, 2015

Health and Human Services Secretary Sylvia Burwell announced goals and a timeline to move the Medicare program toward paying providers based on the quality of care they give patients.